These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 7640539)

  • 1. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J; Hicks NR; Kay JD; Boyd PA
    BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
    Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
    BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the disutility ratio in prenatal screening for Down's syndrome.
    van der Meulen JH; Mol BW; Pajkrt E; van Lith JM; Voorn W
    Br J Obstet Gynaecol; 1999 Feb; 106(2):108-15. PubMed ID: 10426675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region.
    Wellesley D; Boyle T; Barber J; Howe DT
    BMJ; 2002 Jul; 325(7354):15. PubMed ID: 12098722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
    Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
    BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
    Spencer K; Carpenter P
    BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for antenatal detection of Down's syndrome.
    Wyllie JP; Madar RJ; Wright M; Burn J; Wren C
    Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.
    Gilbert RE; Augood C; Gupta R; Ades AE; Logan S; Sculpher M; van Der Meulen JH
    BMJ; 2001 Aug; 323(7310):423-5. PubMed ID: 11520837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.
    Gekas J; Gagné G; Bujold E; Douillard D; Forest JC; Reinharz D; Rousseau F
    BMJ; 2009 Feb; 338():b138. PubMed ID: 19218323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the integrated test in the Down's syndrome screening algorithm.
    Springer D; Loucky J; Tesner P; Cutka D; Stejskal D; Gregor V; Zima T
    J Med Screen; 2018 Sep; 25(3):114-118. PubMed ID: 29575979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
    Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
    BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Alberman E
    BMJ; 2009 Oct; 339():b3794. PubMed ID: 19858532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of a new scheme for prenatal screening for Down's syndrome.
    Sheldon TA; Simpson J
    BMJ; 1991 May; 302(6785):1133-6. PubMed ID: 1710520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
    Ford C; Moore AJ; Jordan PA; Bartlett WA; Wyldes MP; Jones AF; MacKenzie WE
    Br J Obstet Gynaecol; 1998 Aug; 105(8):855-9. PubMed ID: 9746377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Down's syndrome: experience in an inner city health district.
    Saridogan E; Djahanbakhch O; Naftalin AA
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1205-11. PubMed ID: 8968237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.